Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-04-07
2008-09-23
Seamani, Margaret D. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S113000
Reexamination Certificate
active
07427630
ABSTRACT:
The present invention provides compounds of formula (I) including stereoisomers, prodrugs and pharmaceutically acceptable salts or solvates thereofto processes for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of conditions mediated by corticotrophin-releasing factor (CRF).
REFERENCES:
patent: 5006530 (1991-04-01), Angerbauer et al.
patent: 5120782 (1992-06-01), Hubsch et al.
patent: 5169857 (1992-12-01), Angerbauer et al.
patent: 5378700 (1995-01-01), Sakuma et al.
patent: 5401746 (1995-03-01), Angerbauer et al.
patent: 5502187 (1996-03-01), Ayer et al.
patent: 5955613 (1999-09-01), Horvath et al.
patent: 5962479 (1999-10-01), Chen
patent: 6107301 (2000-08-01), Aldrich et al.
patent: 6133282 (2000-10-01), Horvath et al.
patent: 6355651 (2002-03-01), Horvath et al.
patent: 6436932 (2002-08-01), Ge et al.
patent: 6525067 (2003-02-01), Chen
patent: 2002/0111490 (2002-08-01), Horvath et al.
patent: 2004/0110785 (2004-06-01), Wang et al.
patent: 2004/0176400 (2004-09-01), Capelli et al.
patent: 2004/0198726 (2004-10-01), DiFabio et al.
patent: 2004/0235871 (2004-11-01), DiFabio et al.
patent: 2004/0242623 (2004-12-01), DiFabio et al.
patent: 2005/0054661 (2005-03-01), DiFabio et al.
patent: 2007/0021429 (2007-01-01), Yves et al.
patent: 2007/0287705 (2007-12-01), Luo et al.
patent: 2007/0293508 (2007-12-01), Williams et al.
patent: 2007/0293511 (2007-12-01), Luo et al.
patent: 4239440 (1992-11-01), None
patent: 325130 (1989-01-01), None
patent: 414767 (1990-08-01), None
patent: 0465970 (1991-06-01), None
patent: 729758 (1996-02-01), None
patent: 773023 (1997-05-01), None
patent: 1040831 (2000-03-01), None
patent: 1103553 (2000-11-01), None
patent: 2248618 (1992-04-01), None
patent: 7010876 (1995-01-01), None
patent: 11335376 (1999-12-01), None
patent: 2000086663 (2000-03-01), None
patent: WO 91/05784 (1991-05-01), None
patent: WO 92/12718 (1992-08-01), None
patent: WO 93/20078 (1993-10-01), None
patent: WO 95/10506 (1995-04-01), None
patent: WO 95/34563 (1995-12-01), None
patent: WO 98/05661 (1998-02-01), None
patent: WO 98/08846 (1998-05-01), None
patent: WO 98/08847 (1998-05-01), None
patent: WO 98/35967 (1998-08-01), None
patent: WO 98/45295 (1998-10-01), None
patent: WO 99/07703 (1999-02-01), None
patent: WO 99/51599 (1999-10-01), None
patent: WO 00/058301 (2000-10-01), None
patent: WO 00/058307 (2000-10-01), None
patent: WO 00/058313 (2000-10-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 01/23389 (2001-04-01), None
patent: WO 01/53263 (2001-07-01), None
patent: WO 02/02549 (2002-01-01), None
patent: WO 02/019975 (2002-03-01), None
patent: WO 02/055084 (2002-07-01), None
patent: WO 02/088095 (2002-11-01), None
patent: WO 02/100863 (2002-12-01), None
patent: WO 03/008412 (2003-01-01), None
patent: WO 03/022214 (2003-03-01), None
patent: WO 04/000843 (2003-12-01), None
patent: WO2004/062665 (2004-07-01), None
patent: WO 05/063749 (2005-07-01), None
patent: WO 05/063755 (2005-07-01), None
patent: WO 05/063756 (2005-07-01), None
Mulder et al., “Sandwich ELISA for glutathione S-transferase Alpha1-1: plasma concentrations in controls and in patients with gastrointestinal disorders”, Clinical Chemistry, 1996, vol. 42, pp. 416-419.
Di Fabio Romano
Sabbatini Fabio Maria
St-Denis Yves
Madden Laura K.
McCarthy Mary E.
Neurocrine Biosciences Inc.
Rahmani Niloofar
Sauermelch Loretta J.
LandOfFree
Condensed N-heterocyclic compounds and their use as CRF... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Condensed N-heterocyclic compounds and their use as CRF..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Condensed N-heterocyclic compounds and their use as CRF... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3987311